Skip to content
healthcare.dev

ZALEPLON

NDC 57237-239, ZALEPLON, capsule, from Rising Pharma Holdings, Inc..

Product NDC
57237-239
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078829
DEA schedule
CIV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57237-239 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZALEPLON5 mg/1

Pharmacologic classes

Central Nervous System Depression [PE]; GABA A Agonists [MoA]; gamma-Aminobutyric Acid A Receptor Agonist [EPC]

Package NDCNDC-11Package
57237-239-0157237023901100 CAPSULE in 1 BOTTLE (57237-239-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cff46def-c452-49bb-abea-480de8f432bd
  • NADAC price for package 57237023901

    GET /v1/drugs/nadac/57237023901

Use it

Look up 57237-239 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57237-239 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57237-239. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.